APA (7th ed.) Citation

PS, D. (1998). Cost-effectiveness impact of iron dextran on hemodialysis patients' use of epoetin alfa and blood. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 55(24 Suppl 4), S12. https://doi.org/10.1093/ajhp/55.suppl_4.S12

Chicago Style (17th ed.) Citation

PS, Driver. "Cost-effectiveness Impact of Iron Dextran on Hemodialysis Patients' Use of Epoetin Alfa and Blood." American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists 55, no. 24 Suppl 4 (1998): S12. https://doi.org/10.1093/ajhp/55.suppl_4.S12.

MLA (9th ed.) Citation

PS, Driver. "Cost-effectiveness Impact of Iron Dextran on Hemodialysis Patients' Use of Epoetin Alfa and Blood." American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists, vol. 55, no. 24 Suppl 4, 1998, p. S12, https://doi.org/10.1093/ajhp/55.suppl_4.S12.